Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
2 min synopsisUK scopeSources checked 7 Sept 2026Clinical review pending
!
A new sudden change is not ordinary ageing
Someone with established chronic hearing loss can develop a separate acute ear or neurological disorder.
Action: Investigate a new abrupt decline according to the sudden-hearing-loss pathway rather than waiting for the next hearing-aid review. Unexplained loss developing over at most three days within the last 30 days needs ENT or emergency assessment within 24 hours; associated focal neurological findings may require a stroke pathway.
Synopsis
Assess gradual sensory hearing impairment without overlooking atypical features, distinguish cumulative noise risk from ageing, and combine effective hearing rehabilitation with prevention and occupational surveillance.
Age-related loss usually develops gradually and often affects higher-frequency hearing early, making speech less clear despite audible voices.
Noise exposure may contribute over years or cause immediate injury after an extreme event; permanent damage cannot be reversed by simply resting the ear.
Obtain a lifetime occupational and recreational exposure history alongside otoscopy and formal audiometry.
Key red flags
Persistent unilateral or asymmetric impairment, unilateral or pulsatile tinnitus, recurrent vertigo or unexplained fluctuation requires diagnostic assessment rather than an automatic age-related label.
Investigation priorities
01
Otoscopy and clinical hearing assessmentFirst step
Identify reversible disease and determine whether the presentation is suitable for routine audiology.
Management branches
A gradual symmetrical sensory presentationOffer support based on the person's needs
Assessment is consistent with chronic age-related or noise-related impairment without a separate urgent feature.
Explain the findings and discuss hearing aids, communication tactics and assistive listening devices around the patient's chosen goals.
Offer two aids when both ears have aidable loss, and teach device use and troubleshooting in an accessible way.
National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 7 Sept 2026; clinical approval remains outstanding.